Course Overview
Gain a deeper understanding of guideline-directed medical therapy for heart failure. This course explores practical strategies for screening and assessing patients with worsening heart failure and provides insight into novel therapeutic options for those with progressive Heart failure with reduced ejection fraction (HFrEF). Through a practical case study, you’ll gain actionable knowledge to optimize care and improve patient outcomes.
Member Cost: $0Non-member Cost: $0
Credits: 0.75 CE contact hours, 0.75 CE pharmacology hours
Learning Objectives
• Review heart failure guideline-directed medical therapy
• Discuss screening and assessment for worsening heart failure despite guideline-directed medical therapy
• Explore a case study of a patient receiving novel therapeutic agents in patients with progression of HFrEF despite guideline-directed medical therapy
CE certificate available upon successful completion of the post-test and program evaluation.
Faculty
- Tara Whitmire DNP, APRN-NP, CHFN, ACUE
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.